Completely agree here mate, the extraction facility is what gives THC so much advantage and niche in this industry right now. And look at the company Medipharm Labs Corp ( TSE: LABS, 4.92 CAD +0.39 (8.61%)) This company only does extraction and valued at 650 million.
This really is the direction THC could take to get revenue in, they could be the medipharms of australia and south east asia. Although they need to get their act together because medipharm is actually opening up here in australia, dont know how their facility compares with THC, need to research that one. then with the revenue can get there own grow facilties going if they so desire. But really this is where the most profit margin is to be made right now and THC in such a great position to utilise it but they dont seem to be focused on that.
- Forums
- ASX - By Stock
- EPN
- Ann: THC Global Corporate Presentation - Sept 2019
Ann: THC Global Corporate Presentation - Sept 2019, page-106
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EPN (ASX) to my watchlist
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.208M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
EPN (ASX) Chart |
Day chart unavailable